ArticleBreast cancer (Tokyo, Japan)2026

PIK3CA mutation in ER-negative and HER2-positive breast cancer with apocrine differentiation.

Fumi Nozaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.